- Biotie purchases option to acquire Neurelis, Inc. Thomson Reuters ONE - Tue, Jun 4, 2013 4:32 AM EDT
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 4 June 2013 at 11.30 a.m. Biotie purchases option to acquire Neurelis, Inc. Opportunity to develop late-stage product for treatment of epileptic seizures ...
- Medigene's drug Veregen® receives market authorization notification in Taiwan Thomson Reuters ONE - Tue, Jun 4, 2013 2:02 AM EDT
Martinsried/Munich, 4 June, 2013. Medigene AG (MDG, Frankfurt, Prime Standard) announces that its drug Veregen ® has obtained market authorization notification in Taiwan. Market launch of the ointment ...
- Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small … Thomson Reuters ONE - Mon, Jun 3, 2013 11:32 AM EDT
Investigational compound LDK378 is a selective inhibitor of ALK[1], a target found in metastatic non-small cell lung cancer (NSCLC) Data show 60% overall response rate in 78 patients with ALK+ NSCLC taking ...
- Impact of Active Biotech's candidate drug tasquinimod on bone metastases presented at ASCO Thomson Reuters ONE - Mon, Jun 3, 2013 9:05 AM EDT
Tasquinimod Phase II retrospective follow-up study shows an impact of tasquinimod on bone metastases as measured by Bone Scan Index (BSI) Lund (Sweden), June 3, 2013. Active Biotech (NASDAQ OMX NORDIC: ...
- Active Biotech's project ANYARA improved overall survival in a subgroup of renal cell cancer patient … Thomson Reuters ONE - Mon, Jun 3, 2013 9:05 AM EDT
Phase II/III Overall Survival and PFS data presented at the 2013 ASCO Annual Meeting Lund (Sweden), June 3, 2013. Active Biotech (NASDAQ OMX NORDIC: ACTI) today presented overall survival (OS) and Progression ...
- Medtronic Reaches Major Milestone in Clinical Program for 'IN.PACT Admiral' Drug-Eluting Balloon Thomson Reuters ONE - Mon, Jun 3, 2013 7:02 AM EDT
Company Plans to Submit First Module of U.S. Approval Application for Novel Peripheral Angioplasty Device to FDA Over Summer MINNEAPOLIS -- June 3, 2013 -- Continuing to demonstrate its ongoing commitment ...
- Addex Completes Restructuring to Focus on Capturing Potential Upside from its Partnered Asset and CEO … Thomson Reuters ONE - Fri, May 31, 2013 12:05 PM EDT
Geneva, Switzerland, 31 May 2013 - Addex Therapeutics (SIX: ADXN) announced today that it has completed the restructuring previously announced on 27 th May and that Dr.Bharatt Chowrira has stepped down ...
- INC Research Promotes Medical and Oncology Expertise in Support of "Building Bridges to Conquer Cancer" … Thomson Reuters ONE - Fri, May 31, 2013 10:23 AM EDT
Global CRO Offers Specialist Teams for Oncology Drug Development Raleigh, N.C., May 31, 2013 - INC Research , LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® ...
- Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneurysm Repair Thomson Reuters ONE - Fri, May 31, 2013 10:02 AM EDT
Three-Year Clinical Data Presented at Annual Meeting of Society for Vascular Surgery Reaffirms Physician Confidence in Market-Leading Endovascular Device SAN FRANCISCO -- May 31, 2013 -- The Endurant AAA ...
- Bavarian Nordic's IMVANEX® Smallpox Vaccine Receives Positive Opinion from European Regulatory Autho … Thomson Reuters ONE - Fri, May 31, 2013 7:35 AM EDT
KVISTGAARD, Denmark, May 31, 2013 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...
- Lucentis® receives positive opinion for patients with myopic choroidal neovascularization showing vision … Thomson Reuters ONE - Fri, May 31, 2013 7:23 AM EDT
Lucentis recommended for approval in EU to treat patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia Lucentis superior to current standard of care and improves ...
- Uscom to Acquire New Zealand-based Pulsecor and New Blood Pressure Products Business Wire - Thu, May 30, 2013 3:18 AM EDT
Uscom Uscom Limited today signed a deed to acquire all assets of Pulsecor Limited. Pulsecor Limited is a New Zealand company which has developed novel non-invasive central blood pressure measurement methods pioneered at the Weill Cornell Medical College in New York.
- J&B Medical Supply Company Inc. Debuts New Website GlobeNewswire - Thu, May 30, 2013 3:07 AM EDT
WIXOM, Mich. -- via PRWEB - J&B Medical Supply Company Inc. has a brand new website that was designed with the customer's needs in mind. The company's unique medical supply business will help customers ...
- Algeta announces first sale of Xofigo(R) (radium Ra 223 dichloride) in the United States Marketwired - Thu, May 30, 2013 1:29 AM EDT
Algeta ASA announces that Xofigo injection, recently approved by the US Food and Drug Administration for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases ...
- Relapsing MS patients more satisfied with Novartis oral drug Gilenya® than standard injectable therapies, … PR Newswire - Thu, May 30, 2013 1:15 AM EDT
EAST HANOVER, N.J., May 30, 2013 /PRNewswire/ -- People with relapsing multiple sclerosis (MS) reported greater treatment satisfaction after starting the oral treatment Gilenya ® (fingolimod) vs. switching ...
- Sciton Introduces CelluSmooth(TM) for Fast, Long-Lasting and Effective Treatment of Cellulite PR Newswire - Wed, May 29, 2013 10:03 PM EDT
PALO ALTO, California, May 30, 2013 /PRNewswire/ -- Sciton, a leading manufacturer of high-quality custom, modular, multi-application medical laser and light systems for the aesthetic medical market, announces ...
- Ultragenyx to Present at the Jefferies 2013 Global Healthcare Conference GlobeNewswire - Wed, May 29, 2013 7:00 PM EDT
NOVATO, Calif. -- Ultragenyx Pharmaceutical Inc., a biotechnology company, today announced its participation as a presenting company at the Jefferies 2013 Global Healthcare Conference on June 3, 2013. ...
- Sirona Biochem Announces LOI for Collaboration with Cincinnati Children's Hospital Medical Center Marketwired - Wed, May 29, 2013 6:59 PM EDT
Sirona Biochem Corp. is pleased to announce the signing of a Letter of Intent to create a collaboration with Cincinnati Children's Hospital Medical Center. The goal of the collaboration is to create a ...
- Dr. Michael Hunter Honored by Puget Sound Affiliate of Susan G. Komen for the Cure PR Newswire - Wed, May 29, 2013 6:46 PM EDT
KIRKLAND, Wash., May 29, 2013 /PRNewswire/ -- EvergreenHealth is proud to announce that Dr. Michael Hunter – a medical director of the Halvorson Cancer Center – has been honored by Susan G. Komen of Puget ...
- Latteno Files Q1 Financials: Revenue $3.6 Million Up +5,000% from 2012 PR Newswire - Wed, May 29, 2013 6:16 PM EDT
SANTA ANA, Calif., May 29, 2013 /PRNewswire/ -- Latteno Food Corp. (OTCPink: LATF) filed its Q1 Financial Statements and Disclosure with OTCMarkets today, reporting Q1 Revenue of $3,615,018 compared to ...
- LifeScience Alley Board of Directors Elects New Officers Business Wire - Wed, May 29, 2013 5:29 PM EDT
LifeScience Alley announces the election of the following officers to its board of directors: Kathleen Chester, vice president of global regulatory affairs and corporate officer, St.
- Two new GSK oral oncology treatments, BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor … PR Newswire - Wed, May 29, 2013 5:23 PM EDT
LONDON and PHILADELPHIA, May 29, 2013 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved both TAFINLAR ® (dabrafenib) and ...
- Jeffrey Epstein, Science Investor, Applauds Key Discoveries Into Late Onset Alzheimer's PR Newswire - Wed, May 29, 2013 5:22 PM EDT
NEW YORK, May 29, 2013 /PRNewswire/ -- Although there are genetic dispositions for Alzheimer's Disease, the late onset of Alzheimer's and by far the most common, is still a mystery. It's also expected ...
- Elan Provides Shareholders with Categorical View on Value Business Wire - Wed, May 29, 2013 5:12 PM EDT
Elan Corporation, plc today is providing its shareholders and the market with an assessment of Tysabri’s value and Elan’s cash.
- Imaging3, Inc. Announces Chapter 11 Reorganization Plan Confirmed Marketwired - Wed, May 29, 2013 5:10 PM EDT
Imaging3™, Inc. , developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Tuesday May ...
- Helix BioPharma Corp. Initiates Enrollment for Fourth Cohort in Polish Phase I/II Clinical Study of Its … Marketwired - Wed, May 29, 2013 5:05 PM EDT
Helix BioPharma Corp. , a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the opening of patient screening for the fourth dose ...
- Neurocrine Biosciences to Present at the Jefferies 2013 Global Healthcare Conference PR Newswire - Wed, May 29, 2013 5:00 PM EDT
SAN DIEGO, May 29, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting ...
- Kindred Healthcare to Present at Investor Conferences Business Wire - Wed, May 29, 2013 5:00 PM EDT
Kindred Healthcare, Inc. today announced that Benjamin A. Breier, President and Chief Operating Officer, will make a presentation regarding the Company at the Jefferies 2013 Global Healthcare Conference in New York City on Wednesday, June 5, 2013, at 10:30 a.m.
- MannKind to Present at Jefferies 2013 Global Healthcare Conference Business Wire - Wed, May 29, 2013 5:00 PM EDT
MannKind Corporation , focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at the Jefferies 2013 Global Healthcare Conference on Wednesday, June 5, 2013 at 11:00 a.m.
- Study at 43 HCA Hospitals Published in New England Journal of Medicine Business Wire - Wed, May 29, 2013 5:00 PM EDT
HCA , one of the nation’s leading providers of healthcare services, today announced a comprehensive infection prevention study, conducted exclusively at 43 HCA-affiliate
- Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting PR Newswire - Wed, May 29, 2013 4:59 PM EDT
THOUSAND OAKS, Calif., May 29, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will host a webcast investor meeting at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on Saturday, ...
- Coalition Slams "Bullying" Tactics by Premier and Health Minister to Force Through P3 Hospital Privatization … Marketwired - Wed, May 29, 2013 4:58 PM EDT
Attn: Assignment Editor
- Sonoma Hires Eric Swanstrom as Its new Vice President of Sales PR Newswire - Wed, May 29, 2013 4:45 PM EDT
BUFFALO GROVE, Ill., May 29, 2013 /PRNewswire/ -- Sonoma Orthopedic Products (Sonoma) today announced the appointment of Eric Swanstrom as the Vice President of US Sales, effective May 28, 2013. "Eric's ...
- Sirona Biochem Provides Webcast Link for Marcum MicroCap Presentation Marketwired - Wed, May 29, 2013 4:32 PM EDT
Sirona Biochem Corp. today announced the link for the live webcast at the 2nd Annual Marcum MicroCap Conference.
- Hospice Pharmacia Announces Partnership with Drug Buster for Aiding Hospices in Disposal of Unused M … Thomson Reuters ONE - Wed, May 29, 2013 4:32 PM EDT
PHILADELPHIA, PA - May 24, 2013 - Hospice Pharmacia (HP), a service of excelleRx Inc., an Omnicare Company, is now partnering with Drug Buster, the manufacturer of the Drug Disposal System, and offers ...
- Synergy Pharmaceuticals Appoints Patrick H. Griffin, M.D. as Chief Medical Officer GlobeNewswire - Wed, May 29, 2013 4:31 PM EDT
NEW YORK -- Synergy Pharmaceuticals, Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the appointment of Patrick H. Griffin, M. D., FACP as Chief Medical ...
- Edwards Lifesciences Comments on FDA Warning Letter Marketwired - Wed, May 29, 2013 4:28 PM EDT
Edwards Lifesciences Corporation announced today that it has received a warning letter from the Denver District Office of the U.S. Food and Drug Administration resulting from an inspection of Edwards' ...
- / CORRECTION - The San Jose Group Marketwired - Wed, May 29, 2013 4:27 PM EDT
In the news release, "Illinois Home to Nearly 1 Million Uninsured Ethnic Residents," issued Tuesday, May 28, 2013, by The San Jose Group, we are advised by the company that the second sentence ...
- Medical Action Industries Fourth Quarter and Year-End Earnings Call to Take Place on June 11, 2013 GlobeNewswire - Wed, May 29, 2013 4:15 PM EDT
BRENTWOOD, N.Y. -- Medical Action Industries Inc. , announced today that it will hold a conference call on Tuesday, June 11, 2013 at 10:00 a.m. (ET) to present its financial results for the quarter and ...
- Christopher Hayes is Commonwealth Fund's Canadian Harkness Fellow PR Newswire - Wed, May 29, 2013 4:15 PM EDT
OTTAWA, May 29, 2013 /CNW/ - Dr. Christopher Hayes, medical director at St. Michael's Hospital in Toronto, is the recipient of the 2013/14 Canadian Harkness Fellowship, an award co-funded by the Canadian ...
- NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference Business Wire - Wed, May 29, 2013 4:10 PM EDT
NPS Pharmaceuticals, Inc. will present at the Jefferies 2013 Global Healthcare Conference in New York on Monday, June 3, 2013 at 10:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded.
- Accelrys Announces 2013 Process Management & Compliance Suite User Conference PR Newswire - Wed, May 29, 2013 4:09 PM EDT
SAN DIEGO, May 29, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced the final agenda for the 2013 Process Management ...
- Prothena to Present at the Jefferies 2013 Global Healthcare Conference in New York GlobeNewswire - Wed, May 29, 2013 4:05 PM EDT
DUBLIN, Ireland -- Prothena Corporation plc. , a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, ...
- Cempra, Inc. to Present at Jefferies 2013 Global Healthcare Conference PR Newswire - Wed, May 29, 2013 4:05 PM EDT
CHAPEL HILL, N.C., May 29, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present at the Jefferies ...
- The Medicines Company to Participate in Jefferies 2013 Global Healthcare Conference Marketwired - Wed, May 29, 2013 4:02 PM EDT
The Medicines Company is scheduled to present at the Jefferies 2013 Global Healthcare Conference on Tuesday, June 4th at 8:30 AM Eastern Time.
- Presence Health Selects Kaufman Hall’s Software Tools to Support Finance and Planning Functions Business Wire - Wed, May 29, 2013 4:02 PM EDT
Kaufman, Hall and Associates, a leading provider of integrated management software for healthcare organizations, is proud to announce that Presence Health, the largest Catholic hea
- Endocyte to Present at the Jefferies 2013 Global Healthcare Conference GlobeNewswire - Wed, May 29, 2013 4:01 PM EDT
WEST LAFAYETTE, Ind. -- Endocyte, Inc. , a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and ...
- Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences Business Wire - Wed, May 29, 2013 4:00 PM EDT
Alkermes plc announced today that its corporate presentation will be webcast live at the Jefferies 2013 Global Healthcare Conference on Monday, June 3, 2013, at 11:30 a.m.
- Celladon Corporation Selected as Winner of Red Herring's "Top 100 North America Tech Startup" PR Newswire - Wed, May 29, 2013 4:00 PM EDT
SAN DIEGO, May 29, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it ...
- Fourth Annual Jodi's Race for Awareness Set for June 1 Marketwired - Wed, May 29, 2013 3:37 PM EDT
The Fourth Annual Jodi's Race for Awareness, including a 5k Run/Walk and 1 Mile Family Walk, will take place Saturday, June 1, 2013 in Denver's City Park. Registration for the 2013 Jodi's Race is underway ...